- Home
- MBIO vs CDIO Comparison
MBIO vs CDIO Comparison
Compare MBIO & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBIO
- CDIO
- Stock Information
- Founded
- MBIO 2015
- CDIO 2017
- Country
- MBIO United States
- CDIO United States
- Employees
- MBIO N/A
- CDIO N/A
- Industry
- MBIO Biotechnology: Pharmaceutical Preparations
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MBIO Health Care
- CDIO Health Care
- Exchange
- MBIO Nasdaq
- CDIO Nasdaq
- Market Cap
- MBIO 4.7M
- CDIO 5.3M
- IPO Year
- MBIO N/A
- CDIO N/A
- Fundamental
- Price
- MBIO $1.22
- CDIO $3.04
- Analyst Decision
- MBIO
- CDIO
- Analyst Count
- MBIO 0
- CDIO 0
- Target Price
- MBIO N/A
- CDIO N/A
- AVG Volume (30 Days)
- MBIO 81.7K
- CDIO 33.7K
- Earning Date
- MBIO 11-07-2025
- CDIO 11-12-2025
- Dividend Yield
- MBIO N/A
- CDIO N/A
- EPS Growth
- MBIO N/A
- CDIO N/A
- EPS
- MBIO N/A
- CDIO N/A
- Revenue
- MBIO N/A
- CDIO $15,782.00
- Revenue This Year
- MBIO N/A
- CDIO $1,434.82
- Revenue Next Year
- MBIO N/A
- CDIO $4,661.91
- P/E Ratio
- MBIO N/A
- CDIO N/A
- Revenue Growth
- MBIO N/A
- CDIO N/A
- 52 Week Low
- MBIO $0.89
- CDIO $2.68
- 52 Week High
- MBIO $21.95
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- MBIO 35.63
- CDIO 27.65
- Support Level
- MBIO $1.14
- CDIO $3.70
- Resistance Level
- MBIO $1.27
- CDIO $3.50
- Average True Range (ATR)
- MBIO 0.09
- CDIO 0.30
- MACD
- MBIO -0.01
- CDIO -0.12
- Stochastic Oscillator
- MBIO 20.23
- CDIO 3.08
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.